Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Clostridioides difficile M3 (NTCD-M3 spores) are an orally administered live biotherapeutic consisting of a nontoxigenic Clostridioides difficile M3 (lacking the toxin genes) being developed to prevent recurrent C. difficile infection (CDI) by colonization-based competitive exclusion of toxigenic strains after antibiotic treatment
It is formulated as spores (historically also referred to as VP20621) and classified as a live biotherapeutic product under development for CDI prevention rather than treatment of active fulminant disease.
Villano et al. 2012 Antimicrob Agents Ch…